80 results found.
        
NuVasive 3Q17 Revenue +3.2% vs. 3Q16
NuVasive reported 3Q17 revenue of US $247.4MM, +3.2% vs. 3Q16, and year-to-date revenue of $757.9MM, +9.7% vs...
Alphatec Reports Preliminary 3Q17 Revenue
Alphatec Spine reported preliminary, unaudited 3Q17 revenue in a range of US $22.8MM to $23.1MM.
Sales Results for 20 Orthopaedic Companies: A Mid-year Status Report
By Julie A. Vetalice Now that we’ve collected 1H17 results from 20 publicly-traded companies, I’d like to share some performance-based observations. With now just 4 months remaining in the year, these companies provide a helpful gauge in projecting industry growth.
Alphatec Spine Reports 2Q17 Revenue
Alphatec Spine posted 2Q17 revenue of US $24.4MM, -24.4% vs. 2Q16, and 1H17 revenue of $52.4MM, -21.2% vs. ...
Globus Medical Reports 2Q17 Revenue
Globus Medical reported 2Q17 revenue of US $152.4MM, +10.8% vs. 2Q16, and 1H17 revenue of $308.2MM, +11.4% v...
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
Alphatec Spine Reports 1Q17 Revenue
Alphatec Spine posted 1Q17 revenue of US $28.0MM, -18.2% vs. 1Q16.
Globus Medical Reports 1Q17 Revenue
Globus Medical reported 1Q17 revenue of US $155.8MM, +11.9% vs. 1Q16. (U.S. $129.7MM, +1.6%; ex-U.S. $26.1MM, +123.4%...
Globus Medical Company Profile
We're redesigning Company Profiles. To get the most current news and articles about Globus Medical in the interim, pl...
NuVasive Company Profile
We're redesigning Company Profiles. To get the most current news and articles about NuVasive in the interim, please...
Globus Medical Posts 4Q16 and 2016 Revenue
Globus Medical posted 2016 revenue of US $564.0MM, +3.5% vs. 2015, with 4Q16 revenue of $151.6MM, +6.3%
Globus Medical Reports 3Q16 Revenue
Globus Medical posted 3Q16 revenue of US $135.7MM, -1.1% vs. 3Q15. (U.S. $120.5MM, -4.1%, ex-U.S. $15.2MM, +34.1%
NuVasive Reports 2Q16 Revenue
NuVasive reported 2Q16 revenue of US $236.2MM, +16.4% from 2Q15. (U.S. $200.5MM, +12.7%; ex-U.S. $35.6MM, +43.6%)...
Globus Medical Posts 2Q16 Revenue
Globus Medical posted 2Q16 revenue of US $137.5MM, +3.1% vs. 2Q15. (U.S. $124.7MM, +2.7%, ex-U.S. $12.8MM, +5.7%
Alphatec Spine Reports 4Q15/2015 Revenue
Alphatec Spine posted 4Q15 revenue of US $47.0MM, -9.4% vs. 4Q14, and 2015 revenue of $185.3MM, -5.2% v...
Company Revenue 2015: Alphatec Spine
4Q15: $47.0MM, -12.3% 2015: $185.3MM, -10.5% (U.S. 114.6MM, -16.4%; ex-U.S. $70.7MM, +1.1%) (All growth for 4Q and FY is as-reported) ORTHOWORLD estimates 2015 segment revenue and as-reported growth as follows: Spine: $168.5MM, -10.6% Ort...
Alphatec Spine Posts 3Q15 Revenue
Alphatec Spine posted 3Q15 revenue of US $42.9MM, -15.7% as reported, -10.4% in constant currency, and YTD 2015
Alphatec Spine Announces Preliminary 3Q15 Revenue
Alphatec Spine announced preliminary 3Q15 revenue of ~US $43MM (U.S. ~$27.4MM, +0.5%;  ex-U.S. ~$15...
BARE BONES® - August 4, 2015
Alphatec Spine reported 2Q15 revenue of US $46.6MM, -5.6% from 2Q14. (U.S. $27.2MM, -21.1%; ex-U.S. $19.4MM, +23%) Growth reflects constant currency. (
BARE BONES® - April 30, 2015
Alphatec Spine reported 1Q15 revenue of US $48.6MM, +5.4% from 1Q14. (U.S. $30.5MM, -4.9%; ex-U.S. $18.2MM, +24.6%) Growth reflects constant currency. (
BARE BONES® - February 26, 2015
Alphatec Spine posted 4Q14 revenue of US $53.6MM, +4.5% from 4Q13, and 2014 revenue of $207.0MM, +2.5% from 2013. (2014 U.S. $137.1MM, +1.6%; ex-U.S. $69.9MM, +4.4%) Growth re...
2014 Revenue: Alphatec Spine
4Q14 revenue: $53.6MM, +5% (U.S. $35.7MM, flat; ex-U.S. $17.9MM, +14%; U.S. Biologics +14%) 2014 revenue: $207.0MM, +3% (U.S. $137.1MM, +2%; ex-U.S. $69.9MM, +4%)   Estimates global pedicle screw market at ~$4BB, interbody ~$1.5BB (t...
BARE BONES® - October 30, 2014
Alphatec Spine reported 3Q14 revenue of US $51.0MM, +2% vs 3Q13. (U.S. $34.8MM, +3%; ex-U.S. $16.2MM, +1%) Growth reflects constant currency. (
3Q14 Revenue: Alphatec Spine
$51.0MM, +2% (U.S. $34.8MM, +3%; ex-U.S. $16.2MM, +1%) Less Invasive Products +9% overall, +35% ex-U.S. Biologics U.S. +18%   Price had less of an impact in the U.S. than at any time in the last 2 years B...
BARE BONES® - July 31, 2014
Alphatec Spine reported 2Q14 revenue of US $53.2MM, +4.2% from 2Q13. (U.S. $34.5MM, +6.2%; ex-U.S. $18.6MM, +1%) (Growth reflects constant currency.) (
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group